Enasidenib for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Enasidenib for the treatment of acute myeloid leukemia

Published:2018-07-24 Issue:8 Volume:11 Page:755-760
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Dugan James¹,Pollyea Daniel¹

Affiliation:

1. Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1477585

Reference34 articles.

1. Surveillance, epidemiology, and end results (SEER) program (www.seer.cancer.gov) research data (1975-2014). Leukemia – Acute myeloid leukemia (AML), National Cancer Institute, DCCPS, Surveillance Research Program, based on the 2007-2013 SEER 18 data.

2. How I treat acute myeloid leukemia

3. Management of older or unfit patients with acute myeloid leukemia

4. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome:

5. Induction therapy for elderly patients with acute myeloid leukemia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of CYP‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients with Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome;The Journal of Clinical Pharmacology;2024-04-02

2. Integrating Full Bayesian Inference and Student's t‐Distribution Method for Enhanced Outlier Handling in Caffeine Population Pharmacokinetics: Assessing Drug–Drug Interactions with Enasidenib in Relapsed or Refractory AML and MDS Patients;The Journal of Clinical Pharmacology;2024-03-13

3. Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation;Nature Communications;2023-10-30

4. Epigenetics Mechanism and Therapeutic Potential of Approved Epi-drugs in Pulmonary Hypertension Disease;Current Topics in Medicinal Chemistry;2023-08-07

5. An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment;International Journal of Molecular Sciences;2023-03-23